* known prior or current covid-19 infection * previous treatment with btk inhibitor or anti-cd20 therapy other than ofatumumab * no previous vaccination with a non-modrna sars-cov-2 vaccine. other protocol-defined inclusion/exclusion criteria may apply

* known prior or current covid-19 infection * previous treatment with btk inhibitor or anti-cd20 therapy other than ofatumumab * no previous vaccination with a non-modrna sars-cov-2 vaccine. other protocol-defined inclusion/exclusion criteria may apply

* known prior or current covid-19 infection * previous treatment with btk inhibitor or anti-cd20 therapy other than ofatumumab other protocol-defined inclusion/exclusion criteria may apply

* known prior or current covid-19 infection * previous treatment with btk inhibitor or anti-cd20 therapy other than ofatumumab other protocol-defined inclusion/exclusion criteria may apply

- known prior or current covid-19 infection - previous treatment with btk inhibitor or anti-cd20 therapy other than ofatumumab other protocol-defined inclusion/exclusion criteria may apply

- known prior or current covid-19 infection - previous treatment with btk inhibitor or anti-cd20 therapy other than ofatumumab other protocol-defined inclusion/exclusion criteria may apply

- prior or current covid-19 infection - previous treatment with btk inhibitor or anti-cd20 therapy other than ofatumumab other protocol-defined inclusion/exclusion criteria may apply

- prior or current covid-19 infection - previous treatment with btk inhibitor or anti-cd20 therapy other than ofatumumab other protocol-defined inclusion/exclusion criteria may apply